Electrocardiographic Left Ventricular Hypertrophy as a Predictor for Nonsignificant Coronary Artery Disease in Patients With Non-ST-Segment Elevation Myocardial Infarction

Angiology
Naoki MisumidaYumiko Kanei

Abstract

Left ventricular hypertrophy (LVH) can lead to subendocardial ischemia by altering the coronary blood flow and its transmural myocardial distribution in the setting of increased oxygen demand. We hypothesized that electrocardiographic LVH predicts nonsignificant coronary artery disease (CAD) in patients with non-ST-segment elevation myocardial infarction (NSTEMI). We performed a retrospective analysis of 406 consecutive patients with NSTEMI who underwent coronary angiography. The LVH was diagnosed using Sokolow-Lyon and Cornell voltage criteria. Nonsignificant CAD was defined as stenosis less than 50% in the left main and 70% in any other coronary arteries. Of the 406 patients, 100 (25%) patients had electrocardiographic LVH and 99 (24%) patients had nonsignificant CAD. Patients with electrocardiographic LVH had a higher prevalence of nonsignificant CAD (32% vs 22%, P = .04) and a lower rate of in-hospital revascularization (45% vs 69%, P < .001) than those without LVH. On multivariate analysis, electrocardiographic LVH was an independent predictor of nonsignificant CAD (odds ratio 1.94; 95% confidence interval 1.12-3.35; P = .02). In conclusion, electrocardiographic LVH is an independent predictor of nonsignificant CAD and ass...Continue Reading

References

Sep 1, 1985·Journal of the American College of Cardiology·P N CasaleM C Phillips
Aug 14, 2001·Journal of the American College of Cardiology·P A HeidenreichM A Hlatky
Mar 26, 2003·Journal of the American College of Cardiology·Mark A EastEric D Peterson
Jul 5, 2003·The American Journal of Cardiology·Shadi M HamwiJoseph Lindsay
Jan 28, 2004·Circulation·Philippe Gabriel StegUNKNOWN Global Registry of Acute Coronary Events Investigators
Jun 30, 2007·European Heart Journal·Cynthia M WesterhoutUNKNOWN GUSTO IV ACS Investigators
May 22, 2009·The New England Journal of Medicine·Shamir R MehtaUNKNOWN TIMACS Investigators
Sep 11, 2012·Journal of the American College of Cardiology·Kristian ThygesenDaniel R Wagner
Apr 23, 2013·The American Journal of Cardiology·Roberta RossiniDominick J Angiolillo
Nov 12, 2013·The American Journal of Cardiology·Raghava S VelagaletiRamachandran S Vasan

❮ Previous
Next ❯

Citations

May 26, 2016·The American Journal of Emergency Medicine·Akihiro KobayashiYumiko Kanei
May 21, 2019·Experimental and Therapeutic Medicine·Xiao HanQingsheng You

❮ Previous
Next ❯

Methods Mentioned

BETA
coronary artery bypass

Software Mentioned

R

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiogenic Shock

Cardiogenic shock is a devastating consequence of acute myocardial infarction and is associated with an extremely high mortality. Here is the latest research.